AstraZeneca PLCAZNNASDAQ
LOADING
|||

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 10, 2025HSBC
AstraZeneca price target raised to $108 from $95 at HSBC
Target:$108.00
+20.2%from $89.82
Dec 3, 2025Morgan Stanley
AstraZeneca price target raised to $103 from $93 at Morgan Stanley
Target:$103.00
+14.2%from $90.17
Jul 9, 2025Berenberg Bank
AstraZeneca price target raised to $97 from $93 at Berenberg
Target:$97.00
+37.0%from $70.82
Nov 13, 2024BMO Capital
AstraZeneca (AZN) PT Lowered to $88 at BMO Capital
Target:$88.00
+8.4%from $81.19
Sep 11, 2024BMO Capital
BMO Capital Reiterates Outperform Rating on AstraZeneca (AZN)
Target:$89.00
+11.3%from $79.94
May 30, 2024Argus Research
AstraZeneca (AZN) PT Raised to $85 at Argus
Target:$85.00
+10.6%from $76.84
May 28, 2024BMO Capital
BMO Capital Reiterates Outperform Rating on AstraZeneca (AZN)
Target:$82.00
+6.9%from $76.74
Jul 12, 2023Leerink Partners
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Target:$79.00
+21.8%from $64.86
Jan 5, 2023BMO Capital
BMO Capital Initiates Coverage On AstraZeneca with Outperform Rating, Announces Price Target of $82
Target:$82.00
+18.0%from $69.50
Nov 11, 2022Leerink Partners
SVB Leerink Maintains Outperform on AstraZeneca, Raises Price Target to $78
Target:$78.00
+19.8%from $65.09
May 4, 2022Leerink Partners
SVB Leerink Maintains Outperform on AstraZeneca, Raises Price Target to $75
Target:$75.00
+11.7%from $67.17